Patients with chronic dacryocystitis typically present with continuous tearing (epiphora) and a mucopurulent discharge from the eye. There may be swelling and redness over the lacrimal sac area, which is located between the eye and the nose. In some cases, patients may experience discomfort or pain, especially if the area becomes acutely infected. The condition can affect one or both eyes and is more common in adults.

The diagnosis of chronic dacryocystitis is primarily clinical, based on the patient's symptoms and physical examination. A thorough eye examination is essential. Additional tests may include:

• Dacryocystography: An imaging technique to visualize the tear drainage system and identify blockages.
• Lacrimal syringing: A procedure to assess the patency of the nasolacrimal duct.
• Microbiological cultures: To identify any bacterial infection and guide antibiotic therapy.

The primary treatment for chronic dacryocystitis is surgical intervention to restore normal tear drainage. The most common procedure is dacryocystorhinostomy (DCR), which creates a new drainage pathway between the lacrimal sac and the nasal cavity. Antibiotics may be prescribed to manage any active infection before surgery. In some cases, balloon dacryoplasty or stenting may be considered as less invasive options.

With appropriate surgical treatment, the prognosis for chronic dacryocystitis is generally good. Most patients experience significant relief from symptoms and a reduction in the risk of recurrent infections. However, without treatment, the condition can lead to complications such as acute dacryocystitis, abscess formation, or even orbital cellulitis, which is a serious infection of the tissues around the eye.

Chronic dacryocystitis is usually caused by an obstruction in the nasolacrimal duct, which can result from various factors, including:

• Congenital abnormalities: Present from birth.
• Acquired obstructions: Due to trauma, inflammation, or tumors.
• Infections: Recurrent infections can lead to scarring and blockage.
• Age-related changes: Narrowing of the duct with age.

Chronic dacryocystitis is more common in adults, particularly in middle-aged and older women. The condition is less frequent in children, where it is often congenital. The prevalence varies globally, influenced by factors such as environmental conditions and access to healthcare.

The pathophysiology of chronic dacryocystitis involves the obstruction of the nasolacrimal duct, leading to tear retention in the lacrimal sac. This stagnant environment becomes a breeding ground for bacteria, resulting in chronic inflammation and infection. Over time, the persistent inflammation can cause fibrosis and further narrowing of the duct.

Preventing chronic dacryocystitis involves addressing risk factors for nasolacrimal duct obstruction. This includes managing underlying conditions such as sinusitis or allergies, avoiding trauma to the nasal area, and seeking prompt treatment for acute dacryocystitis to prevent chronic progression. Regular eye examinations can help detect early signs of tear drainage issues.

Chronic dacryocystitis is a condition characterized by persistent inflammation of the lacrimal sac due to nasolacrimal duct obstruction. It presents with symptoms like tearing and discharge and is primarily treated through surgical intervention. With timely and appropriate treatment, the prognosis is favorable, although untreated cases can lead to serious complications.

If you experience persistent tearing, discharge, or swelling near the inner corner of your eye, you may have a condition called chronic dacryocystitis. This occurs when the tear drainage system is blocked, leading to infection. Treatment usually involves surgery to open up the drainage pathway, which can significantly improve symptoms. If you notice these symptoms, it's important to consult with a healthcare professional for an accurate diagnosis and appropriate management.